vs
Side-by-side financial comparison of Granite Ridge Resources, Inc. (GRNT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Granite Ridge Resources, Inc. is the larger business by last-quarter revenue ($105.5M vs $57.3M, roughly 1.8× RHYTHM PHARMACEUTICALS, INC.). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -0.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 8.9%).
Granite Ridge Resources, Inc. is an independent upstream energy company focused on the exploration, development, and production of oil, natural gas, and natural gas liquids. It operates low-cost, high-yield onshore hydrocarbon assets across key U.S. basins, primarily serving North American energy markets.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
GRNT vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $105.5M | $57.3M |
| Net Profit | — | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -34.5% | -82.2% |
| Net Margin | — | -83.0% |
| Revenue YoY | -0.8% | 36.9% |
| Net Profit YoY | — | -9.6% |
| EPS (diluted) | $-0.19 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.5M | $57.3M | ||
| Q3 25 | $112.7M | $51.3M | ||
| Q2 25 | $109.2M | $48.5M | ||
| Q1 25 | $122.9M | $32.7M | ||
| Q4 24 | $106.3M | $41.8M | ||
| Q3 24 | $94.1M | $33.3M | ||
| Q2 24 | $90.7M | $29.1M | ||
| Q1 24 | $89.0M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $14.5M | $-52.9M | ||
| Q2 25 | $25.1M | $-46.6M | ||
| Q1 25 | $9.8M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $9.1M | $-43.6M | ||
| Q2 24 | $5.1M | $-32.3M | ||
| Q1 24 | $16.2M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -34.5% | -82.2% | ||
| Q3 25 | 17.4% | -102.6% | ||
| Q2 25 | 19.0% | -93.4% | ||
| Q1 25 | 34.6% | -143.7% | ||
| Q4 24 | -6.5% | -98.6% | ||
| Q3 24 | 26.2% | -132.0% | ||
| Q2 24 | 24.1% | -139.2% | ||
| Q1 24 | 22.0% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | 12.9% | -103.1% | ||
| Q2 25 | 23.0% | -96.1% | ||
| Q1 25 | 8.0% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 9.6% | -131.2% | ||
| Q2 24 | 5.6% | -110.9% | ||
| Q1 24 | 18.2% | -544.4% |
| Q4 25 | $-0.19 | $-0.73 | ||
| Q3 25 | $0.11 | $-0.82 | ||
| Q2 25 | $0.19 | $-0.75 | ||
| Q1 25 | $0.07 | $-0.81 | ||
| Q4 24 | $-0.09 | $-0.71 | ||
| Q3 24 | $0.07 | $-0.73 | ||
| Q2 24 | $0.04 | $-0.55 | ||
| Q1 24 | $0.12 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | $367.8M | — |
| Stockholders' EquityBook value | $605.8M | $139.1M |
| Total Assets | $1.2B | $480.2M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $367.8M | — | ||
| Q3 25 | $300.0M | — | ||
| Q2 25 | $275.0M | — | ||
| Q1 25 | $250.0M | — | ||
| Q4 24 | $205.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $137.5M | — |
| Q4 25 | $605.8M | $139.1M | ||
| Q3 25 | $643.9M | $148.8M | ||
| Q2 25 | $642.5M | $-11.9M | ||
| Q1 25 | $631.4M | $18.9M | ||
| Q4 24 | $635.4M | $21.7M | ||
| Q3 24 | $660.6M | $11.2M | ||
| Q2 24 | $665.3M | $39.3M | ||
| Q1 24 | $674.0M | $61.6M |
| Q4 25 | $1.2B | $480.2M | ||
| Q3 25 | $1.1B | $506.9M | ||
| Q2 25 | $1.1B | $372.7M | ||
| Q1 25 | $1.1B | $386.7M | ||
| Q4 24 | $1.0B | $392.3M | ||
| Q3 24 | $1.0B | $363.6M | ||
| Q2 24 | $990.5M | $381.8M | ||
| Q1 24 | $966.7M | $258.7M |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.5M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.5M | $-25.4M | ||
| Q3 25 | $77.8M | $-26.6M | ||
| Q2 25 | $78.0M | $-23.3M | ||
| Q1 25 | $76.1M | $-40.4M | ||
| Q4 24 | $68.2M | $-18.8M | ||
| Q3 24 | $74.7M | $-25.2M | ||
| Q2 24 | $64.2M | $-29.1M | ||
| Q1 24 | $68.7M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | 5.36× | — | ||
| Q2 25 | 3.11× | — | ||
| Q1 25 | 7.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.25× | — | ||
| Q2 24 | 12.58× | — | ||
| Q1 24 | 4.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRNT
| Oil And Gas Service | $87.6M | 83% |
| Natural Gas Storage | $17.9M | 17% |
RYTM
Segment breakdown not available.
